Sirtuins are nicotinamide adenine dinucleotide (NAD+)-dependent class III histone deacetylases, which have been linked to the pathogenesis of numerous diseases, including HIV, metabolic disorders, neurodegeneration and cancer. Docking of the virtual pan-African natural products library (p-ANAPL), followed by in vitro testing, resulted in the identification of two inhibitors of sirtuin 1, 2 and 3 (sirt1–3). Two bichalcones, known as rhuschalcone IV (8) and an analogue of rhuschalcone I (9), previously isolated from the medicinal plant Rhus pyroides, were shown to be active in the in vitro assay. The rhuschalcone I analogue (9) showed the best activity against sirt1, with an IC50 value of 40.8 µM. Based on the docking experiments, suggestions for improving the biological activities of the newly identified hit compounds have been provided.
Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing
Berin Karaman,Zayan Alhalabi,Sören Swyter,S. Mihigo,K. Andrae-Marobela,M. Jung,W. Sippl,F. Ntie‐Kang
Published 2018 in Molecules
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Molecules
- Publication date
2018-02-01
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-69 of 69 references · Page 1 of 1
CITED BY
Showing 1-24 of 24 citing papers · Page 1 of 1